✦ LIBER ✦

Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer

✍ Scribed by Domingo, E.; Church, D. N.; Sieber, O.; Ramamoorthy, R.; Yanagisawa, Y.; Johnstone, E.; Davidson, B.; Kerr, D. J.; Tomlinson, I. P. M.; Midgley, R.

Book ID: 121387179
Publisher: American Society of Clinical Oncology
Year: 2013
Tongue: English
Weight: 229 KB
Volume: 31
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2013.50.0322

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

471 KRAS, BRAF and PIK3Ca Mutations as P

471 KRAS, BRAF and PIK3Ca Mutations as Predictors of Outcome From Maintenance Therapy with Bevacizumab with or Without Erlotinib After First Line Combination Therapy for Metastatic Colorectal Cancer: Results of the Phase III ACT Trial NCT00598156 Translational Study

✍ Spindler, K.G.; dePont Christensen, R.; Andersen, R.F.; Pallisgaard, N.; Johnson 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Loss of PTEN expression as a predictor o

Loss of PTEN expression as a predictor of resistance to anti-EGFR monoclonal therapy in metastatic colorectal cancer: evidence from retrospective studies

✍ Wang, Zhen-Hua; Gao, Qin-Yan; Fang, Jing-Yuan 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 361 KB

Common colorectal cancer risk variants i

Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: A population-based study of postmenopausal women

✍ Michael N. Passarelli; Anna E. Coghill; Carolyn M. Hutter; Yingye Zheng; Karen W 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 555 KB

## Abstract Common single nucleotide polymorphisms (SNPs) in __SMAD7__ (18q21) have been linked to colorectal cancer (CRC) risk in genome‐wide association studies, but little is known about their effects on survival. SMAD7 regulates gastrointestinal inflammation by inhibiting transforming growth fa